Lithium Exploration (LEXG) 10-Q 7 Sep 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2016	Jul. 27, 2016
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Trading Symbol	lexg
Entity Registrant Name	Lithium Exploration Group, Inc.
Entity Central Index Key	1,375,576
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		119,772,784
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Current
Cash and cash equivalents	$ 7,301	$ 64,098
Receivable	0	13,421
Loan receivable	0	20,000
Prepaid expenses	2,788	2,788
Current assets held for sale .	23,351	14,713
Total current assets	33,440	115,020
Total Assets	33,440	115,020
Current
Accounts payable and accrued liabilities	171,606	65,962
Derivative liability - convertible promissory notes	1,352,033	1,646,448
Derivative liability - warrants	395,536	143,375
Due to related party	115,000	115,000
Convertible promissory notes - net of unamortized discount	811,265	533,994
Accrued interest - convertible promissory notes	124,350	60,022
Current liabilities held for sale	6,439	6,696
Total Current Liabilities	2,976,229	2,571,497
DEFICIT Lithium Explorations Group, Inc. Stockholders' Deficit
Capital stock Authorized: 100,000,000 preferred shares, $0.001 par value Issued and outstanding: Nil preferred shares (June 30, 2015 - Nil)	0	0
Capital stock Authorized: 10,000,000,000 (June 30, 2015 - 2,000,000,000) common shares, $0.001 par value Issued and outstanding: 13,670,617 common shares (June 30, 2015 - 7,574,353)	13,663	7,575
Additional paid-in capital	47,890,759	47,383,232
Accumulated other comprehensive loss	(37,432)	(29,484)
Accumulated deficit	(50,457,687)	(49,504,350)
Total Lithium Exploration Group, Inc. Stockholders' Deficit	(2,590,697)	(2,143,027)
Non-controlling interest	(352,092)	(313,450)
Total Deficit	(2,942,789)	(2,456,477)
Total Liabilities and Deficit	$ 33,440	$ 115,020

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2016	Jun. 30, 2015
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Shares Authorized	10,000,000,000	2,000,000,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	13,670,617	7,574,353
Common Stock, Shares, Outstanding	13,670,617	7,574,353

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Revenue	$ 0	$ 0	$ 0	$ 0
Operating Expenses:
Mining	0	16,212	5,000	31,212
Selling, general and administrative	63,979	359,236	373,393	944,964
Impairment Loss	0	624,429	0	624,429
Total operating expenses	63,979	999,877	378,393	1,600,605
Loss from operations	(63,979)	(999,877)	(378,393)	(1,600,605)
Other income (expenses)
Interest expense	(97,758)	(297,288)	(699,719)	(1,333,193)
Gain (loss) on change in the fair value of derivative liability	112,247	(1,835,099)	576,533	1,083,198
Amortization of debt discount	(78,688)	101,726	(399,010)	(1,483,168)
Bad-debt write off	0	0	(20,000)	0
(Loss) gain on disposal of business operations	(96)	0	7,468	0
Equity in income (loss) of unconsolidated affiliate	0	(6,469)	0	(324)
Other Income	0	80,524	0	80,524
Loss before income taxes	(128,274)	(2,956,483)	(913,121)	(3,253,568)
Provision for Income Taxes	0	0	0	0
Net loss for the period	(128,274)	(2,956,483)	(913,121)	(3,253,568)
Loss from discontinued operations	(290)	(24,078)	(78,860)	(305,966)
Net loss	(128,564)	(2,980,561)	(991,981)	(3,559,534)
Less:Net loss attributable to the non-controlling interest	(142)	(11,798)	(38,642)	(149,923)
Net loss attributable to Lithium Exploration Group, Inc. Common shareholders	$ (128,422)	$ (2,968,763)	$ (953,339)	$ (3,409,611)
Basic and Diluted loss per Common Share	$ (0.01)	$ (7.43)	$ (0.09)	$ (15.28)
Basic and Diluted Weighted Average Number of Common Shares Outstanding	11,742,168	399,318	10,696,351	223,184
Comprehensive loss:
Net loss	$ (128,564)	$ (2,980,561)	$ (991,980)	$ (3,559,534)
Foreign currency translation adjustment	275	(13,997)	(7,947)	(21,831)
Comprehensive loss	(128,289)	(2,994,558)	(999,927)	(3,581,365)
Comprehensive loss attributable to non-controlling interest	(142)	(11,798)	(38,642)	(149,923)
Comprehensive loss attributable to Lithium Exploration Group, Inc.	$ (128,147)	$ (2,982,760)	$ (961,285)	$ (3,431,442)

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Stockholders Deficit - 9 months ended Mar. 31, 2016 - USD ($)	Common Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Non-controlling interest [Member]	Total
Beginning Balance at Jun. 30, 2015	$ 7,574	$ 47,383,232	$ (29,485)	$ (49,504,348)	$ (313,450)	$ (2,456,477)
Beginning Balance (Shares) at Jun. 30, 2015	7,574,353
Common shares issued for debt conversion	$ 6,088	145,078				151,166
Common shares issued for debt conversion (Shares)	6,088,220
Common shares issued for the reclassification of derivative liability on convertible notes		302,262				302,262
Common shares issued for fractional shares adjustment	$ 1					1
Common shares issued for fractional shares adjustment (Shares)	8,044
Disposal of business operations		60,187				60,187
Foreign exchange translation			(7,947)			(7,947)
Net loss for the period				(953,339)	(38,642)	(991,981)
Ending Balance at Mar. 31, 2016	$ 13,663	$ 47,890,759	$ (37,432)	$ (50,457,687)	$ (352,092)	$ (2,942,789)
Ending Balance (Shares) at Mar. 31, 2016	13,670,617

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities
Net loss from continuing operations	$ (913,121)	$ (3,253,568)
Loss from discontinued operations	(78,860)	(305,966)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in income of investment held for sale	0	324
Common shares issued for consulting fees	0	118,991
Non-cash Interest expense	629,248	1,126,957
(Loss) gain on disposal of business operations	(7,468)	0
Impairment Loss	0	624,429
Bad debt written-off	20,000	0
Common shares issued for interest expenses	0	103,048
Gain on change in the fair value of derivative liability	(576,533)	(1,083,198)
Amortization of debt discount	399,010	1,483,168
Common shares issued for investor relations	0	5,000
Changes in operating assets and liabilities:
Receivable, net	13,421	0
Prepaid expenses	0	16,610
Due to related party	0	115,000
Accrued interest	70,471	103,187
Accounts payable and accrued liabilities	105,644	47,178
Net cash used in operating activities from continuing operations	(338,188)	(898,840)
Net cash provided by (used in) operating activities from discontinued operations	51,338	(8,212)
Net cash used in operating activities	(286,850)	(907,052)
Cash Flows from Financing Activities
Repayment to related party	0	(45,332)
Proceed from issuance of convertible promissory notes, net	238,000	954,000
Net cash provided by financing activities	238,000	908,668
Effect of foreign exchange	(7,947)	(21,831)
Decrease in cash and cash equivalents	(56,797)	(20,215)
Cash and cash equivalents - beginning of period	64,098	57,632
Cash and cash equivalents - end of period	7,301	37,417
Cash paid during the period for:
Interest	0	2,205
Income taxes	0	0
Non-cash investing and financing activities:
Common stock issued for debt conversion and interest	151,166	1,499,202
Common stock issued on cashless exercise of warrants	0	2,442,770
Derivative liability re-classed to additional paid in capital	302,262	2,312,157
Debt discount on issuance of convertible note and warrants	230,005	901,327
Initial derivative liability on note issuance and warrants	836,980	2,018,791
Interest reclassed to convertible note	5,680	0
Re-classification of discontinued assets and liabilities to additional paid in capital	$ 60,188	$ 0

Organization

Organization	9 Months Ended
	Mar. 31, 2016
Organization [Text Block]	1. Organization Lithium Exploration Group, Inc. (formerly Mariposa Resources, Ltd.) (the “Company”) was incorporated on May 31, 2006 in the State of Nevada, U.S.A. It is based in Phoenix, Arizona, USA. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is June 30. Effective November 30, 2010, the Company changed its name to “Lithium Exploration Group, Inc.,” by way of a merger with its wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name. A wholly owned subsidiary, 1617437 Alberta Ltd. was incorporated in the province of Alberta, Canada on July 8, 2011. Effective October 2, 2013, the subsidiary changed its name to Alta Disposal Ltd. On October 18, 2013, the Company acquired 51% interest in Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Ltd.). Effective September 4, 2015, the Company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby the Company agrees to sell all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 approximately USD$7,466. On March 1, 2014, the Company through its 100% subsidiary Alta Disposal Ltd. acquired 50% interest in Tero Oilfield Services Ltd. (the “Tero”) On May 1, 2015, the Company entered into a Share Purchase Agreement with an individual and disposed its 50% interest in Tero. The Company is engaged principally in the acquisition, exploration, and development of resource properties. Prior to June 25, 2009, the Company had the right to conduct exploration work on 20 mineral mining claims in Esmeralda County, Nevada, U.S.A. On July 31, 2009, the Company acquired an option to enter into a joint venture for the management and ownership of the Jack Creek Project, a mining project located in Elko County, Nevada. On September 25, 2009, the joint venture was terminated and the Company entered into an agreement with Beeston Enterprises Ltd., under which the Company was granted an option to acquire an undivided 50% interest in eight mineral claims located in the Clinton Mining District of British Columbia, Canada. On December 16, 2010, the Company entered into an Assignment Agreement to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada (see Note 5). On November 8, 2011, the Company entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, the Company was granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Mar. 31, 2016
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the nine months ended March 31, 2016 and 2015 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the nine months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to March 31, 2016 and 2015 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed consolidated balance sheet as of June 30, 2015 was restated during the period ending September 30, 2015 and has been carried forward for the period ending March 31, 2016, and do not include all disclosures required by the accounting principles generally accepted in the United States of America. Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework. Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments. Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively. Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period. Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,” Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive. Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ deficit as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: - assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$. Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,” Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure. Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the unaudited condensed consolidated statements of operations and comprehensive Income (Loss). Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption. Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date. Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured. Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts. Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

Capital Stock

Capital Stock	9 Months Ended
	Mar. 31, 2016
Capital Stock [Text Block]	3. Capital Stock On January 19, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective February 25, 2015. On July 13, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 200 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective March 31, 2016. Upon effect of the reverse stock split the issued and outstanding shares pre-split as at March 31, 2016 were 2,734,123,494 and the post-split were 13,670,617. The Company’s authorized capital will not be affected by the reverse stock split. The split is reflected retrospectively in the accompanying financial statements. Authorized Stock At inception, the Company authorized 100,000,000 common shares and 100,000,000 preferred shares, both with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. On April 8, 2009, the Company increased the number of authorized shares to 600,000,000 shares, of which 500,000,000 shares are designated as common stock par value $0.001 per share, and 100,000,000 shares are designated as preferred stock, par value $0.001 per share. On October 25, 2012, the Company designated 20,000,000 series A convertible preferred stock with a par value of $0.001 per share and stated value of $100 per share. The designated preferred stock is convertible at the option of the holder, at any time beginning one year from the date such shares are issued, into common stock of the Company with a par value of $0.001. All shares of common stock of the Company, shall be of junior rank to all series A preferred stock in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. All other shares of preferred stock shall be of junior rank to all series A preferred shares in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. On January 3, 2014, the Company designated 2,000,000 series B convertible preferred stock with a par value $0.001 per share, issuable only in consideration of the extinguishment of existing debt convertible in to the Company’s common stock with a par value of $0.001. The designated preferred stock shall be issued on the basis of 1 preferred stock for each $1 of convertible debt. The series B convertible preferred stock shall be subordinate to and rank junior to all indebtedness of the Company now or hereafter outstanding. On October 17, 2014, the Company amended its Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of its common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001. The Company's authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001. Effective June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of preferred stock as series A preferred stock. The series A preferred stock, par value $0.001, will rank senior to the Company’s common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The series A preferred stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of series A preferred stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of series A preferred stock will be required for any change to the Company’s Articles of Incorporation. Effective September 9, 2015, the Company increase the authorized capital of its common shares from 2,000,000,000 common shares, par value $0.001 to 10,000,000,000 common shares, par value $0.001. Share Issuances Common Stock Issuance For the period ended March 31, 2016: On July 8, 2015, the Company issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 10, 2015, the Company issued 201,465 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 21, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 22, 2015, the Company issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion (Note 6). On July 29, 2015, the Company issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On August 17, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 15, 2015, the Company issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On October 8, 2015, the Company issued 8,044 common shares at a deemed price of $0.0001 per share to the depository trust as a result of the reverse stock split round-up. On October 28, 2015 the Company issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6). On March 24, 2016 the Company issued 500,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6). On March 28, 2016 the Company issued 600,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On March 29, 2016 the Company issued 450,748 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6). On March 30, 2016 the Company issued 450,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6). Issuances of Preferred Shares On June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, ranks senior to the common stock and carries general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and is not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to articles of incorporation. On July 6, 2015, the Company issued 130,000 Series “A” preferred shares in consideration of the release and discharge of a first ranking general security interest over all current and future assets of Alta Disposal Ltd. that was granted to secure to the promissory note entered into on July 22, 2014. These shares were issued at par value of $0.001. These shares were subsequently cancelled on December 5, 2015 therefore the net impact on share capital is nil.

Provision For Income Taxes

Provision For Income Taxes	9 Months Ended
	Mar. 31, 2016
Provision For Income Taxes [Text Block]	4. Provision for Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Exploration stage deferred tax assets arising as a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. Operating loss carryforwards generated during the period from May 31, 2006 (date of inception) through March 31, 2016 of approximately $13,287,598 will begin to expire in 2026. Accordingly, deferred tax assets were offset by the valuation allowance that increased by approximately $464,277 and $1,130,089 during the periods ended March 31, 2016 and June 30, 2015 respectively. The Company follows the provisions of uncertain tax positions as addressed in FASC 740-10-65-1. The Company recognized approximately no increase in the liability for unrecognized tax benefits. The Company has no tax position at March 31, 2016 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at March 31, 2016. The Company’s utilization of any net operating loss carry forward may be unlikely as a result of its intended exploration stage activities. The tax years for June 30, 2015, June 30, 2014, June 30, 2013 and June 30, 2012 are still open for examination by the Internal Revenue Service (IRS). For the nine months ended March 31, 2016 Amount Tax Effect ( 35%) Net loss $ 913,120 $ 319,592 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest expense (699,718 ) (244,901 ) Gain on derivative liability 576,533 201,787 Amortization of debt discount (399,010 ) (139,654 ) Impairment 7,468 2,614 Total 398,393 139,438 Valuation allowance (398,393 ) (139,438 ) Net deferred tax asset (liability) $ - $ - For the nine months ended March 31, 2015 Amount Tax Effect ( 35%) Net loss $ 3,253,568 $ 1,138,749 Shares issued for consulting fees, mining expenses, investor relation and director fees (118,990 ) (41,647 ) Shares issued for interest expenses (103,048 ) (36,067 ) Amortization of discount (1,483,168 ) (519,109 ) Interest expense (1,333,192 ) (466,617 ) Impairment Loss (624,429 ) (218,550 ) Gain on derivative liability 1,083,198 379,119 Total 673,938 235,878 Valuation allowance (673,938 ) (235,878 ) Net deferred tax asset (liability) $ - $ -

Mineral Property Costs

Mineral Property Costs	9 Months Ended
	Mar. 31, 2016
Mineral Property Costs [Text Block]	5. Mineral Property Costs Mineral Permit (Assignment Agreement with Lithium Exploration VIII Ltd.) On December 16, 2010, the Company entered into an Assignment Agreement to acquire the following: a.) An undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada. b.) All of the assignor’s right, title and interest in and to the Option Agreement. In consideration for the Assignment, the Company agreed to pay US$90,000 by way of cash or stock of equal value (consisting of amounts previously paid by the Assignor pursuant to the Option Agreement). The full $90,000 (consisting of option payments ‘i’ and ‘v’ below) was expensed and included in the December 31, 2011 accounts payable balance. The Option shall be in good standing and exercisable by the Company by paying the following amounts on or before the dates specified in the following schedule: i.) CDN $40,000 (paid) upon execution of the agreement; ii.) CDN $60,000 (paid) on or before January 1, 2012; iii ) CDN $100,000 on or before January 1, 2013 (amended and paid); iv.) CDN $300,000 on or before January 1, 2014 (not paid); and v.) Paying all such property payments as may be required to maintain the mineral permits in good standing. The Optionee shall provide a refundable amount of CDN$50,000 (paid) to the Optionor by November 2, 2010, which shall be applied by the Optionor towards work assessment expenses acceptable to the Government of Alberta, with any unused portion to be applied against payments required to maintain the permits underlying the property in good standing. On December 31, 2012, the Company entered into an agreement to amend the original payment requirement of CDN$100,000 due on January 1, 2013 to the following payments: CDN $20,000 (paid) cash payment due on January 1, 2013 and CDN $80,000 by a 15% one year promissory note starting January 1, 2013. The promissory note is interest free until March 31, 2013. After then, interest will accrue on the principal balance then in arrears at the rate of 15% per annum. No payments shall be payable until December 31, 2013. At any time, the Optionor may elect to convert the remaining balance of CDN $80,000 plus accrued interest into common shares of the Company at 75% of the closing market price of the Company’s common shares on the election day. The full CDN$100,000 (US$95,008) (consisting of cash payment of CDN$20,000 (US$19,164) and note payable of CDN$80,000 (US$75,844) was expensed. The note is subject to be measured at its fair value in accordance with ASC 480-10-25-14. The fair value at issuance was CDN$106,667 (US$101,125) as of June 30, 2013. An additional $26,667 was charged to mining expense during the year June 30, 2013. An interest expense of CDN$3,058 (US$2,899) was accrued as at June 30, 2013. On July 3, 2013, the Optionor elected to convert the promissory note of CDN $80,000 (US$75,844) plus accrued interest of CDN$3,058 (US$2,899) for the total amount of CDN $83,058 (US$78,743) into 239 common shares of the Company at a price of US$330 per share. The January 1, 2014 payment was not paid by the Company, and subsequent to the schedule payment date, the agreement was terminated. Glottech Technology On March 17, 2011 and subsequently amended on November 18, 2011, the Company entered into a letter agreement to acquire one initial unit of proprietary and patented mechanical ultrasound technology for use in water purification, inclusive of its process of separating from water, as the primary fluid stock, the salt and other minerals and by –products contained therein, with Glottech – USA. To acquire the unit, the Company must make the following payments: a) US$25,000 upon execution of the agreement (paid); b) US$75,000 within 180 days of execution of the agreement (paid); c) US$700,000 within 10 days of receipt of invoice from Glottech –USA LLC if the payment in b) is made (paid). d) The Company also granted an option to acquire 500 shares for $1.00 to Glottech – USA upon receipt of the operational ultrasonic generator that they are building for Lithium Exploration Group. The 500 shares are to be paid from outstanding shares owned by Alex Walsh, company CEO. During the year ended June 30, 2011, the option resulting in additional mining expenses of $4,940,000 was valued using the fair market value of the shares to be issued. On October 1, 2012, Alex Walsh and GD International entered into an agreement to transfer 500 common shares owned by Alex Walsh to GD International. The shares were received by GD International on October 29, 2012. Commencing as of the end of an initial sixty day testing and training period following satisfactory delivery and physical setup of the technology, and continuing thereafter for as long as the technology remains in the possession of the Company, the Company shall pay continuing monthly royalties in an amount equal to $2.00 per physical ton of water processed pursuant to the usage of the technology. On June 12, 2012, the Company filed a complaint with the court of common pleas of Chester County, Pennsylvania against Glottech – USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. The complaint seeks an order of the court granting possession of the unit, in its current state, to the Company. Effective August 14, 2012, the Company entered into an option agreement with GD Glottech-International, Limited (“GD International”) to protect our license and distribution rights in the event that GD-Glottech-USA, LLC (“GD USA”) is unable to perform and honor the obligations contingent to a letter agreement dated November 8, 2011. Pursuant to the terms of the option agreement, we are required to provide an initial deposit of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. A further $15,000 was required for exercising the option agreement and it will be credited to future fees when patents rights are exercised. We exerised this option agreement on September 1, 2012 and released the funds to GD International. On October 1, 2012, the Company entered into a sales agency agreement with GD International. The agreement shall replace all agreements entered previously. Pursuant to the agreement, the Company is appointed as GD International’s sales agent for the technology within the territory. As a consideration, 10,000 common shares of the Company shall be issued to GD International (issued: see d) above). GD International retains all right, title and interest in the technology. The term of this agreement will be an initial period of five years. The term shall be automatically renewable thereafter for successive five year periods provided that the Company has sold not less than 25 or more technology units during each applicable five year period. On May 2, 2013, the Company entered into an agreement to retain the future use of the unit. Pursuant to the agreement, the Company must make the following payments: a) US$20,000 within three days of execution of the agreement (paid); b) US$30,000 within three days upon the testing of the unit has been successfully completed.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Mar. 31, 2016
Convertible Promissory Notes [Text Block]	6. Convertible Promissory Notes Summary of convertible promissory note at March 31, 2016 and June 30, 2015 is as follows: June 30, Principal Interest Total converted Total March 31, 2016 2015 Issued Converted to repaid Principal February 13, 2013 $ 67,913 $ - $ - $ (33,680 ) $ - $ 34,233 March 15, 2014 29,394 - 5,681 (29,938 ) - 5,137 July 22, 2014 540,498 - - (52,872 ) - 487,626 August 22, 2014 37,242 - - (5,200 ) - 32,042 February 6, 2015 75,000 - - (26,475 ) - 48,525 February 24, 2015 100,000 - - - 100,000 March 3, 2015 29,000 - - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - - 36,000 September 9, 2015 - 30,000 - - - 30,000 September 30, 2015 - 27,000 - - - 27,000 November 06,2015 - 12,000 - - - 12,000 December 01, 2015 - 18,000 - - - 18,000 December 01, 2015 - 18,000 - - - 18,000 December 03, 2015 - 17,000 - - - 17,000 January 27, 2016 - 24,750 - - - 24,750 January 27, 2016 - 5,000 - - - 5,000 March 01, 2016 - 13,200 - - - 13,200 March 24, 2016 - 12,100 - - - 12,100 March 28, 2016 - 40,700 - - - 40,700 $ 879,047 $ 253,750 $ 5,681 $ (151,165 ) $ $ 987,313 Less: Unamortized debt discount $ (345,053 ) $ (176,047 ) Total note payable, net of debt discount $ 533,994 $ 811,265 Current portion $ 533,994 $ 811,265 Long term portion $ - $ - The Company during the period and subsequently has extended the maturity dates on few of the Convertible Promissory Notes. On August 3, 2015 the Company issued an aggregate of $36,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,720 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17% The initial fair values of the embedded debt derivative of $33,231 was allocated as a debt discount up to the proceeds of the note with the remainder $19,489 was charged to current period operations as interest expense. The note matured during the period however, no repayment was made. An agreement was entered into by the investor and the Company and the maturity of the note has been extended by a year. On September 9, 2015, the Company issued an aggregate of $30,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $54,495 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39% The initial fair values of the embedded debt derivative $30,000 was allocated as a debt discount up to the proceeds of the note with the remainder $24,495 was charged to current period operations as interest expense. On September 30, 2015, Company issued an aggregate of $27,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $306,808 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33% The initial fair values of the embedded debt derivative $27,000 was allocated as a debt discount up to the proceeds of the note with the remainder $279,808 was charged to current period operations as interest expense. On November 6, 2015, the Company issued an aggregate of $12,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $115,109 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 383.46% Risk free rate: 0.47% The initial fair values of the embedded debt derivative of $12,000 was allocated as a debt discount up to the proceeds of the note with the remainder $103,109 charged to operations as interest expense. On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense. On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense. On December 3, 2015, the Company issued an aggregate of $17,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $27,706 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 394.55% Risk free rate: 0.57% The initial fair values of the embedded debt derivative of $17,000 was allocated as a debt discount up to the proceeds of the note with the remainder $10,706 charged to operations as interest expense. On January 27, 2016, the Company issued an aggregate of $24,750 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $45,731 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 383.68% Risk free rate: 0.47% The initial fair values of the embedded debt derivative of $22,846 was allocated as a debt discount with the remainder $22,885 charged to operations as interest expense. On January 27, 2016, the Company issued an aggregate of $5,500 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $9,239 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 383.68% Risk free rate: 0.47% The initial fair values of the embedded debt derivative of $4,615 was allocated as a debt discount with the remainder $4,623 charged to operations as interest expense. On March 01, 2016, the Company issued an aggregate of $13,200 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $29,217 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 371.21% Risk free rate: 0.68% The initial fair values of the embedded debt derivative of $13,200 was allocated as a debt discount up to the proceeds of the note with the remainder $16,017 charged to operations as interest expense. On March 24, 2016, the Company issued an aggregate of $12,100 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $17,671 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 371.21% Risk free rate: 0.64% The initial fair values of the embedded debt derivative of $6,515 was allocated as a debt discount with the remainder $11,156 charged to operations as interest expense. On March 28, 2016, the Company issued an aggregate of $40,700 Convertible Promissory Notes that mature in a specified period from the date of issuance. These notes bear interest and are convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $36,293 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 371.21% Risk free rate: 0.65% The initial fair values of the embedded debt derivative of $21,915 was allocated as a debt discount with the remainder $14,378 charged to operations as interest expense. During the three and nine months period ended March 31, 2016 the Company amortized the debt discount on all the notes of $78,688 and $399,010 to operations as interest expense, respectively. During the three and nine months period ended March 31, 2015 the Company amortized the debt discount on all the notes of $(101,727) and $1,483,168 to operations as interest income and expense, respectively. Derivative Liability- Debt The fair value of the described embedded derivative on all debt was valued at $1,352,033 and $1,646,448 at March 31, 2016 and June 30, 2015, respectively, which was determined using the Black Scholes Model with the following assumptions: March 31, 2016 June 30, 2015 Dividend yield: 0% 0% Volatility 346.6 – 453.3% 258.89% Risk free rate: 0.39%- 0.66% 0.11% - 0.64% At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on debt to market resulting in non-cash, non-operating gain of $828,693 and loss of $904,458 for the nine months ended March 31, 2016 and 2015, respectively and for the three months ending March 31, 2016 and March 31, 2015, the non-cash, non-operating loss of $241,359 and $723,955 was recorded respectively. During the nine months ended March 31, 2016 the Company issued 6,088,220 no of shares of the Company common stock in settlement of $151,165 of convertible note and interest. During the nine months ended March 31, 2016 the Company reclassed the derivative liability of $302,262 to additional paid in capital on conversion of convertible note. The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015: Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,066,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2015 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 836,980 Fair value of liability at note conversion (302,262 ) Mark-to-market at March 31, 2016 (829,133 ) Balance, March 31, 2016 $ 1,352,033 Net gain for the period included in earnings relating to the liabilities held at March 31, 2016 $ 829,133 Derivative Liability- Warrants Along with the promissory notes, the Company issued warrants that bear a cashless exercise provision. The warrants also include anti-dilution protection with respect to lower priced issuances of common stock or securities convertible or exchangeable into common stock, which provision resulted in derivative liability treatment under ASC 480. The warrants are recorded at fair value using the Black-Scholes option pricing model and marked-to-market at each reporting period, with the changes in the fair value recorded in the consolidated statement of operations and comprehensive income (loss). During the nine months ended March 31, 2016 no warrants were issued along with convertible note. The fair value of the described embedded derivative on all warrants was valued at $395,535 at March 31, 2016 and $143,375 at June 30, 2015 which was determined using the Black Scholes Model with the following assumptions: March 31, 2016 June 30, 2015 Dividend yield: 0% 0% Volatility 248.0 – 272.2% 288.96% Risk free rate: .87 – 1.21% 1.01 - 1.63% Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, March 31, 2016 27,092 $ 100.99 3.04 years The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of March 31, 2016 and June 30, 2015: Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2015 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at March 31, 2016 – warrant liability 252,160 Balance, March 31, 2016 $ 395,536 Net loss for the period included in earnings relating to the liabilities held at March 31, 2016 $ 252,160 At March 31, 2016 and 2015, the Company adjusted the recorded fair value of the derivative liability on warrants to market resulting in non-cash, non-operating loss of $252,160 and gain of $1,987,656 for the nine months ended March 31, 2016 and 2015, respectively. Non-cash, non-operating gain of $354,046 and loss of $1,111,145 was recorded for the three months ended March 31, 2016 and March 31, 2015 respectively. During the nine months ended March 31, 2016 the Company reclassed the derivative liability on warrants of $0 to additional paid in capital on exercise of warrants.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Mar. 31, 2016
Related Party Transactions [Text Block]	7. Related Party Transactions During the nine months ended March 31, 2016, the Company incurred consulting fees of $1,115 (June 30, 2015 - $157,086) with directors and officers out of which there were no stock payments (June 30, 2015 - $58,990 were paid by issuance of 2,167 shares of the Company common stock). As of March 31, 2016, the Company repaid to a director for a non-interest bearing demand loan of $nil (Note 9) (June 30, 2015 – payable $47,537). These transactions are in the normal course of operations and are measured at the exchange amount of consideration established and agreed to by the related parties.

Going Concern and Liquidity Con

Going Concern and Liquidity Considerations	9 Months Ended
	Mar. 31, 2016
Going Concern and Liquidity Considerations [Text Block]	8. Going Concern and Liquidity Considerations The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As at March 31, 2016, the Company had a working capital deficiency of $2,942,788 (June 30, 2015 - $2,456,477) and an accumulated deficit of $50,457,687 (June 30, 2015 - $49,504,350). The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months. The ability of the Company to emerge from the exploration stage is dependent upon, among other things, obtaining additional financing to continue operations, explore and develop the mineral properties and the discovery, development and sale of ore reserves. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2016
Commitments and Contingencies [Text Block]	9. Commitments and Contingencies Employment Agreements On January 12, 2014, the Company entered into an employment agreement with a director and officer. Commencing on January 12, 2014, the director and officer will be employed for 24 months ending on January 12, 2016. Pursuant to the agreement, annual salary of US$120,000 is payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. Consulting Agreements On January 1, 2014, the Company entered in a consulting agreement with a consultants to provide services as members of the Board of Directors in regards to the Company’s management and operations. The compensation for the services to be provided will be $12,000 payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. The consulting agreement was amended on October 22, 2014 to include an additional aggregate of $30,000 payable as of October 22, 2014 in cash or in shares of the Company’s common stock, and changed the term of agreement from 12 months to 10 months. Effective November 1, 2014, the consultant resigned as member of the Board of Directors. On April 28, 2014, the Company entered into a consulting agreement with a consultant to provide services as members of the Board of Directors in regards to the Company’s management and operations. Pursuant to the terms of the agreement, the consultant will receive compensation of $12,000 in unregistered restricted common shares of the Company's common stock at a deemed value of $200.0 per share, issuable on May 15, 2014, effective April 28, 2014 to April 27, 2015. The consultant resigned as member of the Board of Directors and these shares were not issued. On May 30, 2014, the Company entered into a consulting agreement with a consultant to provide services as member of the Board of Directors in regards to the Company’s management and operation. The compensation for the services to be provided will be $10,000 per month payable in common stock of the Company from a period of six months from the effective date of May 30, 2014. On August 1, 2014, the Company entered into a consulting agreement with a consultant to provide advice relative to corporate and business services and to perform other related activities. Pursuant to the terms of the agreement, the Company will issue 500 common shares of the Company valued at $68,000. These shares were issued in full effective October 22, 2014. Lease Commitment On May 15, 2014, the Company entered into a sublease agreement for a term of twenty four and one half months and expiring on May 31, 2016. Future minimum rental payments required under operating lease (exclusive of other additional rent payments) are $4,563. Litigation From time to time we may be a defendant and plaintiff in various other legal proceedings arising in the normal course of our business. Except as disclosed above, we are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date of this Annual Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us.

Loan Receivable

Loan Receivable	9 Months Ended
	Mar. 31, 2016
Loan Receivable [Text Block]	10. Loan Receivable Secured Bridge Loan Agreement On December 18, 2013, the Company entered into an agreement with GD Glottech International Ltd (“GDGI”) whereby the Company loaned to GDGI the sum of $20,000. GDGI will repay the total amount of the loan plus interest in the amount of $333.34 (representing a 10% annual interest rate), within sixty (60) days from the receipt of the loan funds or within five (5) days of Sonic Cavitation, LLC receiving a 5% Capital Contribution. On April 21, 2014, the Company entered into an amended agreement with Sonic Cavitation, whereby Sonic Cavitation agreed to facilitate the construction of one sonic cavitation generator. The Company agreed to pay Sonic Cavitation a consulting fee of $20,000 upon execution of the agreement and forgive the sum of $20,000 debt upon delivery of the prototype by Sonic Cavitation. The agreement has been executed, however the delivery of the prototype has not yet fulfilled. During the nine months ending March 31, 2016, the directors of the company decided that the loan is irrecoverable and has been written off to $nil.

Discontinued Operations

Discontinued Operations	9 Months Ended
	Mar. 31, 2016
Discontinued Operations [Text Block]	11. Discontinued Operations On September 4, 2015, the Company entered into an Asset Purchase agreement whereby the Company sells the net assets of Alta Disposal Morinville Ltd. (of which the Company had acquired 51% interest on October 18, 2013) for total purchase price of CDN$10,000. Operating results for the period ended March 31, 2016 and 2015 for Alta Disposal Morinville Ltd. are presented as discontinued operations and the assets and liabilities classified as held for sale are presented separately in the consolidated balance sheet. A breakdown of the discontinued operations is presented as follow: Consolidated Statements of Operations and Comprehensive Loss March 31, 2016 March 31, 2015 (unaudited) (unaudited) Revenue $ - $ 54,476 Selling, general and administrative $ (78,860 ) (363,442 ) Loss from discontinued operations $ (78,860 ) $ (305,966 ) Consolidated Balance Sheets March 31, 2016 June 30, 2015 (unaudited) (restated) Current assets: Cash and cash equivalents $ 5,731 $ 46,731 Receivable, net 653 28,160 Prepaid expenses 683 - GST Receivable 16,284 - Impairment of net assets - (60,178 ) $ 23,351 $ 14,713 Current liabilities: Accounts payable $ 6,439 $ 6,696

Subsequent Events

Subsequent Events	9 Months Ended
	Mar. 31, 2016
Subsequent Events [Text Block]	12. Subsequent Events On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $50,000, with $5,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On April 19, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,000, with an issuance discount of $2,500 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On May 16, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $30,250, with an issuance discount of $2,750 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On August 12, 2016, our company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $42,500, with an issuance discount of $4,250 and $2,500 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of our company’s common stock. On September 1, 2016, our company entered into letter agreements with five separate investors with the intent to buyout their notes and warrants. Pursuant to the terms of the agreement, the investors have agreed to a standstill period until September 16, 2016. The buyout will take place over a six month period of time and will result in an aggregate of $252,856 in debt being retired, an aggregate of $195,500 in warrants being retired and an aggregate buyout amount of $460,000 will be paid over the period. Additionally the Company will also issue an aggregate of $232,500 in new convertible debt. Conversion Price for note will be 65% of the lowest trading price of the Common Stock as reported on the OTC Markets electronic quotation service or such marketplace. Note will have no prepayment penalties and can be purchased from the holder at face value. On September 2, 2016 our company entered into a bridge loan in the amount of $50,000 with 10% interest per annum due November 2, 2016. The following conversions took place subsequent to the period ending March 31, 2016. On April 4, 2016 the Company issued 160,043 common shares at a deemed price of $0.0126 per share for promissory note conversion. On April 4, 2016 the Company issued 650,000 common shares at a deemed price of $0.026 per share for promissory note conversion. On April 4, 2016 the Company issued 641,025 common shares at a deemed price of $0.0252 per share for promissory note conversion. On April 5, 2016 the Company issued 227,770 common shares at a deemed price of $0.011 per share for promissory note conversion. On April 6, 2016 the Company issued 490,027 common shares at a deemed price of $0.01807 per share for promissory note conversion. On April 7, 2016 the Company issued 267,396 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 8, 2016 the Company issued 591,620 common shares at a deemed price of $0.009329 per share for promissory note conversion. On April 8, 2016 the Company issued 769,230 common shares at a deemed price of $0.0126 per share for promissory note conversion. On April 11, 2016 the Company issued 500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 12, 2016 the Company issued 776,000 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 13, 2016 the Company issued 775,000 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 13, 2016 the Company issued 669,222 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 13, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion. On April 11, 2016 the Company issued 575,327 common shares at a deemed price of $0.010985 per share for promissory note conversion. On April 14, 2016 the Company issued 790,000 common shares at a deemed price of $0.007500 per share for promissory note conversion. On April 14, 2016 the Company issued 803,725 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 14, 2016 the Company issued 846,153 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 17, 2016 the Company issued 1,128,205 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 18, 2016 the Company issued 819,493 common shares at a deemed price of $0.010595 per share for promissory note conversion. On April 19, 2016 the Company issued 850,000 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 19, 2016 the Company issued 1,041,960 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 19, 2016 the Company issued 750,312 common shares at a deemed price of $0.009329 per share for promissory note conversion. On April 20, 2016 the Company issued 750,000 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 21, 2016 the Company issued 469,119 common shares at a deemed price of $0.010595 per share for promissory note conversion. On April 21, 2016 the Company issued 1,048,416 common shares at a deemed price of $0.007500 per share for promissory note conversion. On April 22, 2016 the Company issued 1,140,474 common shares at a deemed price of $0.0075 per share for promissory note conversion. On April 22, 2016 the Company issued 1,100,000 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 22, 2016 the Company issued 256,410 common shares at a deemed price of $0.00975 per share for promissory note conversion. On April 26, 2016 the Company issued 923,077 common shares at a deemed price of $0.0065 per share for promissory note conversion. On April 26, 2016 the Company issued 1,600,000 common shares at a deemed price of $0.00715 per share for promissory note conversion. On April 28, 2016 the Company issued 1,500,000 common shares at a deemed price of $0.0065 per share for promissory note conversion. On April 28, 2016 the Company issued 1,007,941 common shares at a deemed price of $0.0065 per share for promissory note conversion. On April 29, 2016 the Company issued 769,231 common shares at a deemed price of $0.0065 per share for promissory note conversion. On April 29, 2016 the Company issued 1,214,575 common shares at a deemed price of $0.0076 per share for promissory note conversion. On April 29, 2016 the Company issued 1,529,480 common shares at a deemed price of $0.007500 per share for promissory note conversion. On April 29, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion. On May 2, 2016 the Company issued 1,700,000 common shares at a deemed price of $0.00494 per share for promissory note conversion. On May 2, 2016 the Company issued 1,514,380 common shares at a deemed price of $0.002 per share for promissory note conversion. On May 3, 2016 the Company issued 1,586,538 common shares at a deemed price of $0.0026 per share for promissory note conversion. On May 3, 2016 the Company issued 1,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion. On May 5, 2016 the Company issued 2,302,321 common shares at a deemed price of $0.00145 per share for promissory note conversion. On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion. On May 5, 2016 the Company issued 2,000,000 common shares at a deemed price of $0.002 per share for promissory note conversion. On May 9, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion. On May 9, 2016 the Company issued 5,500,000 common shares at a deemed price of $0.00115 per share for promissory note conversion. On May 9, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00125 per share for promissory note conversion. On May 9, 2016, the Company issued 6,100,000 common shares at a deemed price of $0.00075 per share for promissory note conversion $4575. On May 10, 2016 the Company issued 3,200,000 common shares at a deemed price of $0.000750 per share for promissory note conversion. On May 10, 2016 the Company issued 3,100,000 common shares at a deemed price of $0.000975 per share for promissory note conversion. On May 10, 2016 the Company issued 6,600,000 common shares at a deemed price of $0.00075 per share for promissory note conversion. On May 11, 2016 the Company issued 6,000,000 common shares at a deemed price of $0.00075 per share for promissory note conversion. On May 11, 2016 the Company issued 3,500,000 common shares at a deemed price of $0.00975 per share for promissory note conversion. On May 12, 2016 the Company issued 2,500,000 common shares at a deemed price of $0.001625 per share for promissory note conversion. On May 12, 2016 the Company issued 4,000,000 common shares at a deemed price of $0.000845 per share for promissory note conversion. On May 13, 2016 the Company issued 9,717,385 common shares at a deemed price of $0.00055 per share for promissory note conversion. On May 12, 2016 the Company issued 7,900,000 common shares at a deemed price of $0.0065 per share for promissory note conversion. Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the nine months period ending March 31, 2016, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the nine months period ending March 31, 2015 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated. The Company has evaluated subsequent events from April 1, 2016, through the date of this report, and determined there are no other items to disclose.

Restatement to previously issue

Restatement to previously issued financial statements	9 Months Ended
	Mar. 31, 2016
Restatement to previously issued financial statements [Text Block]	13. Restatement to previously issued financial statements The following tables reflect the corrections to the affected line items in the previously issued financial statements as of and for the years ended June 30, 2015 and for the period ended March 31, 2015. Effect on Condensed Consolidated Balance Sheet Year ended June 30, 2015 As previously Effect of As Restated reported Restatement ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,098 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,020 Total Assets $ 115,021 $ - $ 115,020 LIABILITIES AND DEFICIT Current Accounts payable and accrued liabilities $ 65,962 $ - $ 65,962 Derivative liability – warrants 3,134 140,241 143,375 Derivative liability – convertible promissory notes - 1,646,448 1,646,448 Due to related party 115,000 - 115,000 Convertible promissory notes 300,887 233,107 533,994 Accrued interest – convertible promissory notes 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,019,796 $ 2,571,497 STOCKHOLDERS DEFICIT Capital stock Nil preferred shares - - - 7,574,353 common shares 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,027 ) Non-controlling interest (313,450 ) - (313,450 ) Total Deficit (436,680 ) (2,019,796 ) (2,456,477 ) Total Liabilities and Deficit $ 115,021 $ - $ 115,020 Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) Nine months ended March 31, 2015 As previously reported Effect of Restatement As Restated Revenue $ 57,476 $ (57,476 ) $ - Operating Expenses: Mining (Notes 3 & 5) 31,212 - 31,212 Selling, general and administrative (Notes 3 & 5) 1,308,405 (363,441 ) 944,964 Impairment Loss 624,429 - 624,429 Total operating expenses 1,964,046 (363,441 ) 1,600,605 (Loss) from operations (1,906,570 ) (305,965 ) (1,600,605 ) Other income (expenses) Interest expense (Note 6) (2,818,008 ) 1,484,816 (1,333,192 ) Other Income 80,524 - 80,524 Gain on change in the fair value of derivative liability (Note 6) 3,638,090 (1,763,485 ) 1,874,605 Fair Value of Warrants issued (962,309 ) 170,902 (791,407 ) Amortization of discount on debt discount - (1,483,168 ) (1,483,168 ) Equity in income of investment held for sale (324 ) - (324 ) Loss before income taxes (1,968,597 ) (1,284,971 ) (3,253,568 ) Provision for Income Taxes (Note 4) - - - Loss from continuing operations (1,968,597 ) (1,284,971 ) (3,253,568 ) Loss from discontinued operations - (305,966 ) (305,966 ) Net loss (1,968,597 ) (1,590,937 ) (3,559,534 ) Less: Net loss attributable to the non-controlling interest (149,923 ) - (149,923 ) Net loss attributable to Lithium Exploration Group, Inc. Common $ (1,818,674 ) $ (1,590,937 ) $ (3,409,611 ) Basic and Diluted loss per Common Share 0.04 (15.24 ) (15.28 ) Basic and Diluted Weighted Average Number of Common Shares Outstanding 44,636,800 (44,413,616 ) 223,184 Comprehensive loss : Net loss (1,968,597 ) (1,590,937 ) (3,559,534 ) Foreign currency translation adjustment (21,831 ) - (21,831 ) Comprehensive loss (1,990,428 ) (1,590,937 ) (3,581,365 ) Comprehensive loss attributable to non-controlling interest (149,923 ) - (149,923 ) Comprehensive loss attributable to Lithium Exploration Group, Inc. $ (1,840,505 ) $ (1,590,937 ) $ (3,431,442 ) Effect on Condensed Consolidated Statements of Cash Flows Nine months ending March 31, 2015 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net loss from continuing operations $ (1,968,597 ) $ (1,284,971 ) $ (3,253,568 ) Loss from discontinued operations - (305,966 ) (305,966 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale 324 - 324 Common shares issued for consulting fees 118,990 - 118,990 Common shares issued for investor relations 5,000 - 5,000 Interest expense 2,611,775 (1,484,818 ) 1,126,957 Amortization of discount on derivative liabilities - 1,483,168 1,483,168 Bad debt written-off - - - Common shares issued for interest expenses 103,048 - 103,048 Gain on change in the fair value of derivative liability (3,638,090 ) 1,763,485 (1,874,605 ) Fair value of warrants issued 962,309 (170,902 ) 791,407 Due to related party 115,000 - 115,000 Impairment Loss 624,429 - 624,429 Changes in operating assets and liabilities: Receivable, net (7,412 ) 7,412 - Prepaid expenses 19,074 (2,464 ) 16,610 Accrued interest 103,185 2 103,187 Accounts payable and accrued liabilities 52,968 (5,790 ) 47,178 Net cash used in operating activities from continuing operations (887,997 ) (843 ) (898,840 ) Net cash used in operating activities from discontinued operations - (8,212 ) (8,212 ) Net cash used in operating activities (897,997 ) (9,055 ) (907,052 ) Cash Flows from Financing Activities Repayment of related party (45,332 ) - (45,332 ) Proceed from issuance of convertible promissory notes 954,000 - 954,000 Net cash provided by financing activities 908,668 - 908,668 Effect of foreign exchange (21,831 ) - (21,831 ) Decrease in cash and cash equivalents (11,160 ) (9,055 ) (20,215 ) Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 58,572 (21,155 ) $ 37,417 Supplementary disclosure of cash flow information: Cash paid during the period for: Interest $ 2,205 (2,205 ) $ - Income taxes $ - $ - Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 2,536,097 $ (1,036,895 ) $ 1,499,202 Transfer of beneficial conversion feature to fair value of note $ 518,808 $ (518,808 ) $ - Common stock issued on cashless exercise of warrants $ 779,600 $ 1,663,170 $ 2,442,770 Derivative liability re-classed to additional paid in capital $ - $ 2,312,157 $ 2,312,157 Debt discount on convertible note and warrants $ - $ 901,327 $ 901,327 Initial derivative liability on note issuance $ - $ 2,018,791 $ 2,018,791 Effect on Condensed Consolidated Statements of Changes in Stockholders’ Deficit Year ended June 30, 2015 As previously Misstatement reported Adjustment As Restated Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net Income (Loss) for the year (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net Income (Loss) for the year (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 )

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2016
Basis of presentation and consolidation [Policy Text Block]	Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the nine months ended March 31, 2016 and 2015 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the nine months ended March 31, 2016 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to March 31, 2016 and 2015 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed consolidated balance sheet as of June 30, 2015 was restated during the period ending September 30, 2015 and has been carried forward for the period ending March 31, 2016, and do not include all disclosures required by the accounting principles generally accepted in the United States of America.
Principal of Consolidation [Policy Text Block]	Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.
Use of Estimates [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.
Cash and Cash Equivalents [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $7,301 and $64,098 in cash and cash equivalents at March 31, 2016 and June 30, 2015, respectively.
Concentration of Risk [Policy Text Block]	Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of March 31, 2016 and June 30, 2015, the Company had no deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts.
Prepaid expenses [Policy Text Block]	Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.
Start-Up Costs [Policy Text Block]	Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,”
Mineral Acquisition and Exploration Costs [Policy Text Block]	Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.
Concentrations of Credit Risk [Policy Text Block]	Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.
Net Income or (Loss) per Share of Common Stock [Policy Text Block]	Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.
Foreign Currency Translations [Policy Text Block]	Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ deficit as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: - assets and liabilities are translated at period-end exchange rates prevailing at that reporting date; and Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending March 31, 2016 closing rate at 0.771 CDN$: US$, average rate at 0.7468 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.
Comprehensive Income (Loss) [Policy Text Block]	Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,”
Risks and Uncertainties [Policy Text Block]	Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.
Environmental Expenditures [Policy Text Block]	Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.
Warrants [Policy Text Block]	Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the unaudited condensed consolidated statements of operations and comprehensive Income (Loss).
Convertible Instruments [Policy Text Block]	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption.
Fair Value of Financial Instruments [Policy Text Block]	Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.
Revenue Recognition [Policy Text Block]	Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.
Income Taxes [Policy Text Block]	Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.
Receivables [Policy Text Block]	Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.
Recent Accounting Pronouncements [Policy Text Block]	Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.
FASB Statements [Policy Text Block]	FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

Provision For Income Taxes (Tab

Provision For Income Taxes (Tables)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	For the nine months ended March 31, 2016 Amount Tax Effect ( 35%) Net loss $ 913,120 $ 319,592 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest expense (699,718 ) (244,901 ) Gain on derivative liability 576,533 201,787 Amortization of debt discount (399,010 ) (139,654 ) Impairment 7,468 2,614 Total 398,393 139,438 Valuation allowance (398,393 ) (139,438 ) Net deferred tax asset (liability) $ - $ -	For the nine months ended March 31, 2015 Amount Tax Effect ( 35%) Net loss $ 3,253,568 $ 1,138,749 Shares issued for consulting fees, mining expenses, investor relation and director fees (118,990 ) (41,647 ) Shares issued for interest expenses (103,048 ) (36,067 ) Amortization of discount (1,483,168 ) (519,109 ) Interest expense (1,333,192 ) (466,617 ) Impairment Loss (624,429 ) (218,550 ) Gain on derivative liability 1,083,198 379,119 Total 673,938 235,878 Valuation allowance (673,938 ) (235,878 ) Net deferred tax asset (liability) $ - $ -

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	9 Months Ended
	Mar. 31, 2016
Schedule of Summary of Convertible Promissory Note [Table Text Block]	June 30, Principal Interest Total converted Total March 31, 2016 2015 Issued Converted to repaid Principal February 13, 2013 $ 67,913 $ - $ - $ (33,680 ) $ - $ 34,233 March 15, 2014 29,394 - 5,681 (29,938 ) - 5,137 July 22, 2014 540,498 - - (52,872 ) - 487,626 August 22, 2014 37,242 - - (5,200 ) - 32,042 February 6, 2015 75,000 - - (26,475 ) - 48,525 February 24, 2015 100,000 - - - 100,000 March 3, 2015 29,000 - - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - - 36,000 September 9, 2015 - 30,000 - - - 30,000 September 30, 2015 - 27,000 - - - 27,000 November 06,2015 - 12,000 - - - 12,000 December 01, 2015 - 18,000 - - - 18,000 December 01, 2015 - 18,000 - - - 18,000 December 03, 2015 - 17,000 - - - 17,000 January 27, 2016 - 24,750 - - - 24,750 January 27, 2016 - 5,000 - - - 5,000 March 01, 2016 - 13,200 - - - 13,200 March 24, 2016 - 12,100 - - - 12,100 March 28, 2016 - 40,700 - - - 40,700 $ 879,047 $ 253,750 $ 5,681 $ (151,165 ) $ $ 987,313 Less: Unamortized debt discount $ (345,053 ) $ (176,047 ) Total note payable, net of debt discount $ 533,994 $ 811,265 Current portion $ 533,994 $ 811,265 Long term portion $ - $ -
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	March 31, 2016 June 30, 2015 Dividend yield: 0% 0% Volatility 346.6 – 453.3% 258.89% Risk free rate: 0.39%- 0.66% 0.11% - 0.64%
Schedule of Changes in Fair Value of Convertible Promissory Notes [Table Text Block]	Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,066,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2015 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 836,980 Fair value of liability at note conversion (302,262 ) Mark-to-market at March 31, 2016 (829,133 ) Balance, March 31, 2016 $ 1,352,033 Net gain for the period included in earnings relating to the liabilities held at March 31, 2016 $ 829,133
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]	March 31, 2016 June 30, 2015 Dividend yield: 0% 0% Volatility 248.0 – 272.2% 288.96% Risk free rate: .87 – 1.21% 1.01 - 1.63%
Schedule of Stockholders' Equity Warrants Activity [Table Text Block]	Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, March 31, 2016 27,092 $ 100.99 3.04 years
Schedule of Changes in Fair Value of Financial Liabilities [Table Text Block]	Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2015 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at March 31, 2016 – warrant liability 252,160 Balance, March 31, 2016 $ 395,536 Net loss for the period included in earnings relating to the liabilities held at March 31, 2016 $ 252,160
August 3, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17%
September 9, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39%
September 30, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33%
November 6, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 383.46% Risk free rate: 0.47%
December 1, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51%
December 1, 2015 Embedded Derivatives (2) [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51%
December 3, 2015 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 394.55% Risk free rate: 0.57%
January 27, 2016 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 383.68% Risk free rate: 0.47%
January 27, 2016 Embedded Derivatives (2) [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 383.68% Risk free rate: 0.47%
March 1, 2016 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 371.21% Risk free rate: 0.68%
March 24, 2016 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 371.21% Risk free rate: 0.64%
March 28, 2016 Embedded Derivatives [Member]
Schedule of Valuation Assumptions [Table Text Block]	Dividend yield: 0% Volatility 371.21% Risk free rate: 0.65%

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Mar. 31, 2016
Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss [Table Text Block]	March 31, 2016 March 31, 2015 (unaudited) (unaudited) Revenue $ - $ 54,476 Selling, general and administrative $ (78,860 ) (363,442 ) Loss from discontinued operations $ (78,860 ) $ (305,966 )
Schedule of Discontinued Operations, Consolidated Balance Sheets [Table Text Block]	Consolidated Balance Sheets March 31, 2016 June 30, 2015 (unaudited) (restated) Current assets: Cash and cash equivalents $ 5,731 $ 46,731 Receivable, net 653 28,160 Prepaid expenses 683 - GST Receivable 16,284 - Impairment of net assets - (60,178 ) $ 23,351 $ 14,713 Current liabilities: Accounts payable $ 6,439 $ 6,696

Restatement to previously iss24

Restatement to previously issued financial statements (Tables)	9 Months Ended
	Mar. 31, 2016
Schedule of Effect on Condensed Consolidated Balance Sheet [Table Text Block]	Year ended June 30, 2015 As previously Effect of As Restated reported Restatement ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,098 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,020 Total Assets $ 115,021 $ - $ 115,020 LIABILITIES AND DEFICIT Current Accounts payable and accrued liabilities $ 65,962 $ - $ 65,962 Derivative liability – warrants 3,134 140,241 143,375 Derivative liability – convertible promissory notes - 1,646,448 1,646,448 Due to related party 115,000 - 115,000 Convertible promissory notes 300,887 233,107 533,994 Accrued interest – convertible promissory notes 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,019,796 $ 2,571,497 STOCKHOLDERS DEFICIT Capital stock Nil preferred shares - - - 7,574,353 common shares 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,027 ) Non-controlling interest (313,450 ) - (313,450 ) Total Deficit (436,680 ) (2,019,796 ) (2,456,477 ) Total Liabilities and Deficit $ 115,021 $ - $ 115,020
Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) [Table Text Block]	Nine months ended March 31, 2015 As previously reported Effect of Restatement As Restated Revenue $ 57,476 $ (57,476 ) $ - Operating Expenses: Mining (Notes 3 & 5) 31,212 - 31,212 Selling, general and administrative (Notes 3 & 5) 1,308,405 (363,441 ) 944,964 Impairment Loss 624,429 - 624,429 Total operating expenses 1,964,046 (363,441 ) 1,600,605 (Loss) from operations (1,906,570 ) (305,965 ) (1,600,605 ) Other income (expenses) Interest expense (Note 6) (2,818,008 ) 1,484,816 (1,333,192 ) Other Income 80,524 - 80,524 Gain on change in the fair value of derivative liability (Note 6) 3,638,090 (1,763,485 ) 1,874,605 Fair Value of Warrants issued (962,309 ) 170,902 (791,407 ) Amortization of discount on debt discount - (1,483,168 ) (1,483,168 ) Equity in income of investment held for sale (324 ) - (324 ) Loss before income taxes (1,968,597 ) (1,284,971 ) (3,253,568 ) Provision for Income Taxes (Note 4) - - - Loss from continuing operations (1,968,597 ) (1,284,971 ) (3,253,568 ) Loss from discontinued operations - (305,966 ) (305,966 ) Net loss (1,968,597 ) (1,590,937 ) (3,559,534 ) Less: Net loss attributable to the non-controlling interest (149,923 ) - (149,923 ) Net loss attributable to Lithium Exploration Group, Inc. Common $ (1,818,674 ) $ (1,590,937 ) $ (3,409,611 ) Basic and Diluted loss per Common Share 0.04 (15.24 ) (15.28 ) Basic and Diluted Weighted Average Number of Common Shares Outstanding 44,636,800 (44,413,616 ) 223,184 Comprehensive loss : Net loss (1,968,597 ) (1,590,937 ) (3,559,534 ) Foreign currency translation adjustment (21,831 ) - (21,831 ) Comprehensive loss (1,990,428 ) (1,590,937 ) (3,581,365 ) Comprehensive loss attributable to non-controlling interest (149,923 ) - (149,923 ) Comprehensive loss attributable to Lithium Exploration Group, Inc. $ (1,840,505 ) $ (1,590,937 ) $ (3,431,442 )
Schedule of Effect on Condensed Consolidated Statements of Cash Flows [Table Text Block]	Nine months ending March 31, 2015 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net loss from continuing operations $ (1,968,597 ) $ (1,284,971 ) $ (3,253,568 ) Loss from discontinued operations - (305,966 ) (305,966 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale 324 - 324 Common shares issued for consulting fees 118,990 - 118,990 Common shares issued for investor relations 5,000 - 5,000 Interest expense 2,611,775 (1,484,818 ) 1,126,957 Amortization of discount on derivative liabilities - 1,483,168 1,483,168 Bad debt written-off - - - Common shares issued for interest expenses 103,048 - 103,048 Gain on change in the fair value of derivative liability (3,638,090 ) 1,763,485 (1,874,605 ) Fair value of warrants issued 962,309 (170,902 ) 791,407 Due to related party 115,000 - 115,000 Impairment Loss 624,429 - 624,429 Changes in operating assets and liabilities: Receivable, net (7,412 ) 7,412 - Prepaid expenses 19,074 (2,464 ) 16,610 Accrued interest 103,185 2 103,187 Accounts payable and accrued liabilities 52,968 (5,790 ) 47,178 Net cash used in operating activities from continuing operations (887,997 ) (843 ) (898,840 ) Net cash used in operating activities from discontinued operations - (8,212 ) (8,212 ) Net cash used in operating activities (897,997 ) (9,055 ) (907,052 ) Cash Flows from Financing Activities Repayment of related party (45,332 ) - (45,332 ) Proceed from issuance of convertible promissory notes 954,000 - 954,000 Net cash provided by financing activities 908,668 - 908,668 Effect of foreign exchange (21,831 ) - (21,831 ) Decrease in cash and cash equivalents (11,160 ) (9,055 ) (20,215 ) Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 58,572 (21,155 ) $ 37,417 Supplementary disclosure of cash flow information: Cash paid during the period for: Interest $ 2,205 (2,205 ) $ - Income taxes $ - $ - Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 2,536,097 $ (1,036,895 ) $ 1,499,202 Transfer of beneficial conversion feature to fair value of note $ 518,808 $ (518,808 ) $ - Common stock issued on cashless exercise of warrants $ 779,600 $ 1,663,170 $ 2,442,770 Derivative liability re-classed to additional paid in capital $ - $ 2,312,157 $ 2,312,157 Debt discount on convertible note and warrants $ - $ 901,327 $ 901,327 Initial derivative liability on note issuance $ - $ 2,018,791 $ 2,018,791
Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit [Table Text Block]	Year ended June 30, 2015 As previously Misstatement reported Adjustment As Restated Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net Income (Loss) for the year (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net Income (Loss) for the year (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 )

Organization (Narrative) (Detai

Organization (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2016CAD
Organization 1	1,617,437	1,617,437
Organization 2	51.00%	51.00%
Organization 3 | CAD		CAD 10,000
Organization 4 | $	$ 7,466
Organization 5	100.00%	100.00%
Organization 6	50.00%	50.00%
Organization 7	50.00%	50.00%
Organization 8	20	20
Organization 9	50.00%	50.00%
Organization 10	100.00%	100.00%

Significant Accounting Polici26

Significant Accounting Policies (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Significant Accounting Policies 1	51.00%
Significant Accounting Policies 2	$ 7,301
Significant Accounting Policies 3	$ 64,098
Significant Accounting Policies 4	0.771
Significant Accounting Policies 5	0.7468
Significant Accounting Policies 6	0.8017
Significant Accounting Policies 7	0.8518
Significant Accounting Policies 8	$ 0
Significant Accounting Policies 9	$ 18,984

Capital Stock (Narrative) (Deta

Capital Stock (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)yr$ / sharesshares
Capital Stock 1	20
Capital Stock 2	1
Capital Stock 3	200
Capital Stock 4	1
Capital Stock 5	2,734,123,494
Capital Stock 6	13,670,617
Capital Stock 7	100,000,000
Capital Stock 8	100,000,000
Capital Stock 9 | $ / shares	$ 0.001
Capital Stock 10	600,000,000
Capital Stock 11	500,000,000
Capital Stock 12 | $ / shares	$ 0.001
Capital Stock 13	100,000,000
Capital Stock 14 | $ / shares	$ 0.001
Capital Stock 15	20,000,000
Capital Stock 16 | $ / shares	$ 0.001
Capital Stock 17 | $ / shares	$ 100
Capital Stock 18 | $	$ 0.001
Capital Stock 19	2,000,000
Capital Stock 20 | $ / shares	$ 0.001
Capital Stock 21 | $	$ 0.001
Capital Stock 22	1
Capital Stock 23 | $	$ 1
Capital Stock 24	500,000,000
Capital Stock 25 | $	$ 0.001
Capital Stock 26	2,000,000,000
Capital Stock 27 | $	$ 0.001
Capital Stock 28	2,000,000,000
Capital Stock 29	100,000,000
Capital Stock 30 | $	$ 0.001
Capital Stock 31	50,000,000
Capital Stock 32	100,000,000
Capital Stock 33 | $	$ 0.001
Capital Stock 34	62
Capital Stock 35 | yr	1
Capital Stock 36	75.00%
Capital Stock 37	2,000,000,000
Capital Stock 38 | $	$ 0.001
Capital Stock 39	10,000,000,000
Capital Stock 40 | $	$ 0.001
Capital Stock 41	125,000
Capital Stock 42 | $ / shares	$ 0.04
Capital Stock 43	201,465
Capital Stock 44 | $ / shares	$ 0.04
Capital Stock 45	250,000
Capital Stock 46 | $ / shares	$ 0.04
Capital Stock 47	100,000
Capital Stock 48 | $ / shares	$ 0.05
Capital Stock 49	298,269
Capital Stock 50 | $ / shares	$ 0.04
Capital Stock 51	250,000
Capital Stock 52 | $ / shares	$ 0.04
Capital Stock 53	80,801
Capital Stock 54 | $ / shares	$ 0.04
Capital Stock 55	434,084
Capital Stock 56 | $ / shares	$ 0.03
Capital Stock 57	438,000
Capital Stock 58 | $ / shares	$ 0.03
Capital Stock 59	486,623
Capital Stock 60 | $ / shares	$ 0.02
Capital Stock 61	475,000
Capital Stock 62 | $ / shares	$ 0.03
Capital Stock 63	394,231
Capital Stock 64 | $ / shares	$ 0.03
Capital Stock 65	8,044
Capital Stock 66 | $ / shares	$ 0.0001
Capital Stock 67	554,000
Capital Stock 68 | $ / shares	$ 0.01
Capital Stock 69	500,000
Capital Stock 70 | $ / shares	$ 0.01
Capital Stock 71	600,000
Capital Stock 72 | $ / shares	$ 0.03
Capital Stock 73	450,748
Capital Stock 74 | $ / shares	$ 0.01
Capital Stock 75	450,000
Capital Stock 76 | $ / shares	$ 0.01
Capital Stock 77	50,000,000
Capital Stock 78	100,000,000
Capital Stock 79 | $	$ 0.001
Capital Stock 80	62
Capital Stock 81 | yr	1
Capital Stock 82	75.00%
Capital Stock 83	130,000
Capital Stock 84 | $	$ 0.001
Capital Stock 85	0

Provision For Income Taxes (Nar

Provision For Income Taxes (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Provision For Income Taxes 1	$ 13,287,598
Provision For Income Taxes 2	464,277
Provision For Income Taxes 3	$ 1,130,089

Mineral Property Costs (Narrati

Mineral Property Costs (Narrative) (Details) - 9 months ended Mar. 31, 2016	USD ($)d$ / sharesshares	CADdshares
Mineral Property Costs 1	100.00%	100.00%
Mineral Property Costs 2	$ 90,000
Mineral Property Costs 3	$ 90,000
Mineral Property Costs 4 | CAD		CAD 40,000
Mineral Property Costs 5 | CAD		60,000
Mineral Property Costs 6 | CAD		100,000
Mineral Property Costs 7 | CAD		300,000
Mineral Property Costs 8 | CAD		50,000
Mineral Property Costs 9 | CAD		100,000
Mineral Property Costs 10 | CAD		20,000
Mineral Property Costs 11 | CAD		CAD 80,000
Mineral Property Costs 12	15.00%	15.00%
Mineral Property Costs 13	15.00%	15.00%
Mineral Property Costs 14 | CAD		CAD 80,000
Mineral Property Costs 15	75.00%	75.00%
Mineral Property Costs 16 | CAD		CAD 100,000
Mineral Property Costs 17	$ 95,008
Mineral Property Costs 18 | CAD		20,000
Mineral Property Costs 19	19,164
Mineral Property Costs 20 | CAD		80,000
Mineral Property Costs 21	75,844
Mineral Property Costs 22 | CAD		106,667
Mineral Property Costs 23	101,125
Mineral Property Costs 24	26,667
Mineral Property Costs 25 | CAD		3,058
Mineral Property Costs 26	2,899
Mineral Property Costs 27 | CAD		80,000
Mineral Property Costs 28	75,844
Mineral Property Costs 29 | CAD		3,058
Mineral Property Costs 30	2,899
Mineral Property Costs 31 | CAD		CAD 83,058
Mineral Property Costs 32	$ 78,743
Mineral Property Costs 33 | shares	239	239
Mineral Property Costs 34 | $ / shares	$ 330
Mineral Property Costs 35	$ 25,000
Mineral Property Costs 36	$ 75,000
Mineral Property Costs 37 | d	180	180
Mineral Property Costs 38	$ 700,000
Mineral Property Costs 39 | d	10	10
Mineral Property Costs 40 | shares	500	500
Mineral Property Costs 41	$ 1
Mineral Property Costs 42 | shares	500	500
Mineral Property Costs 43	$ 4,940,000
Mineral Property Costs 44 | shares	500	500
Mineral Property Costs 45	$ 2
Mineral Property Costs 46	150,000
Mineral Property Costs 47	$ 15,000
Mineral Property Costs 48 | shares	10,000	10,000
Mineral Property Costs 49	25	25
Mineral Property Costs 50	$ 20,000
Mineral Property Costs 51	$ 30,000

Convertible Promissory Notes (N

Convertible Promissory Notes (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes 1	$ 36,000
Convertible Promissory Notes 2	10.00%
Convertible Promissory Notes 3	$ 52,720
Convertible Promissory Notes 4	33,231
Convertible Promissory Notes 5	19,489
Convertible Promissory Notes 6	$ 30,000
Convertible Promissory Notes 7	10.00%
Convertible Promissory Notes 8	$ 54,495
Convertible Promissory Notes 9	30,000
Convertible Promissory Notes 10	24,495
Convertible Promissory Notes 11	$ 27,000
Convertible Promissory Notes 12	10.00%
Convertible Promissory Notes 13	$ 306,808
Convertible Promissory Notes 14	27,000
Convertible Promissory Notes 15	279,808
Convertible Promissory Notes 16	12,000
Convertible Promissory Notes 17	115,109
Convertible Promissory Notes 18	12,000
Convertible Promissory Notes 19	103,109
Convertible Promissory Notes 20	18,000
Convertible Promissory Notes 21	72,119
Convertible Promissory Notes 22	18,000
Convertible Promissory Notes 23	54,119
Convertible Promissory Notes 24	18,000
Convertible Promissory Notes 25	72,119
Convertible Promissory Notes 26	18,000
Convertible Promissory Notes 27	54,119
Convertible Promissory Notes 28	17,000
Convertible Promissory Notes 29	27,706
Convertible Promissory Notes 30	17,000
Convertible Promissory Notes 31	10,706
Convertible Promissory Notes 32	24,750
Convertible Promissory Notes 33	45,731
Convertible Promissory Notes 34	22,846
Convertible Promissory Notes 35	22,885
Convertible Promissory Notes 36	5,500
Convertible Promissory Notes 37	9,239
Convertible Promissory Notes 38	4,615
Convertible Promissory Notes 39	4,623
Convertible Promissory Notes 40	13,200
Convertible Promissory Notes 41	29,217
Convertible Promissory Notes 42	13,200
Convertible Promissory Notes 43	16,017
Convertible Promissory Notes 44	12,100
Convertible Promissory Notes 45	17,671
Convertible Promissory Notes 46	6,515
Convertible Promissory Notes 47	11,156
Convertible Promissory Notes 48	40,700
Convertible Promissory Notes 49	36,293
Convertible Promissory Notes 50	21,915
Convertible Promissory Notes 51	14,378
Convertible Promissory Notes 52	78,688
Convertible Promissory Notes 53	399,010
Convertible Promissory Notes 54	(101,727)
Convertible Promissory Notes 55	1,483,168
Convertible Promissory Notes 56	1,352,033
Convertible Promissory Notes 57	1,646,448
Convertible Promissory Notes 58	828,693
Convertible Promissory Notes 59	904,458
Convertible Promissory Notes 60	241,359
Convertible Promissory Notes 61	$ 723,955
Convertible Promissory Notes 62	6,088,220
Convertible Promissory Notes 63	$ 151,165
Convertible Promissory Notes 64	302,262
Convertible Promissory Notes 65	395,535
Convertible Promissory Notes 66	143,375
Convertible Promissory Notes 67	252,160
Convertible Promissory Notes 68	1,987,656
Convertible Promissory Notes 69	354,046
Convertible Promissory Notes 70	1,111,145
Convertible Promissory Notes 71	$ 0

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)shares
Related Party Transactions 1	$ 1,115
Related Party Transactions 2	157,086
Related Party Transactions 3	$ 58,990
Related Party Transactions 4 | shares	2,167
Related Party Transactions 5	$ 0
Related Party Transactions 6	$ 47,537

Going Concern and Liquidity C32

Going Concern and Liquidity Considerations (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Going Concern And Liquidity Considerations 1	$ 2,942,788
Going Concern And Liquidity Considerations 2	2,456,477
Going Concern And Liquidity Considerations 3	50,457,687
Going Concern And Liquidity Considerations 4	$ 49,504,350

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)mo$ / shares$ / moshares
Commitments And Contingencies 1 | mo	24
Commitments And Contingencies 2	$ 120,000
Commitments And Contingencies 3	12,000
Commitments And Contingencies 4	$ 30,000
Commitments And Contingencies 5 | mo	12
Commitments And Contingencies 6 | mo	10
Commitments And Contingencies 7	$ 12,000
Commitments And Contingencies 8 | $ / shares	$ 200
Commitments And Contingencies 9 | $ / mo	10,000
Commitments And Contingencies 10 | shares	500
Commitments And Contingencies 11	$ 68,000
Commitments And Contingencies 12	$ 4,563

Loan Receivable (Narrative) (De

Loan Receivable (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Loan Receivable 1	$ 20,000
Loan Receivable 2	$ 333.34
Loan Receivable 3	10.00%
Loan Receivable 4	5.00%
Loan Receivable 5	$ 20,000
Loan Receivable 6	20,000
Loan Receivable 7	$ 0

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016CAD
Discontinued Operations 1	51.00%
Discontinued Operations 2	CAD 10,000

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)$ / sharesshares
Subsequent Events 1	10.00%
Subsequent Events 2 | $	$ 50,000
Subsequent Events 3 | $	$ 5,000
Subsequent Events 4	10.00%
Subsequent Events 5 | $	$ 50,000
Subsequent Events 6 | $	$ 5,000
Subsequent Events 7	10.00%
Subsequent Events 8 | $	$ 30,000
Subsequent Events 9 | $	2,500
Subsequent Events 10 | $	$ 2,500
Subsequent Events 11	10.00%
Subsequent Events 12 | $	$ 30,250
Subsequent Events 13 | $	2,750
Subsequent Events 14 | $	$ 2,500
Subsequent Events 15	10.00%
Subsequent Events 16 | $	$ 42,500
Subsequent Events 17 | $	4,250
Subsequent Events 18 | $	2,500
Subsequent Events 19 | $	252,856
Subsequent Events 20 | $	195,500
Subsequent Events 21 | $	460,000
Subsequent Events 22 | $	$ 232,500
Subsequent Events 23	65.00%
Subsequent Events 24 | $	$ 50,000
Subsequent Events 25	10.00%
Subsequent Events 15 | shares	160,043
Subsequent Events 16 | $ / shares	$ 0.0126
Subsequent Events 17 | shares	650,000
Subsequent Events 18 | $ / shares	$ 0.026
Subsequent Events 19 | shares	641,025
Subsequent Events 20 | $ / shares	$ 0.0252
Subsequent Events 21 | shares	227,770
Subsequent Events 22 | $ / shares	$ 0.011
Subsequent Events 25 | shares	490,027
Subsequent Events 26 | $ / shares	$ 0.01807
Subsequent Events 27 | shares	267,396
Subsequent Events 28 | $ / shares	$ 0.0075
Subsequent Events 29 | shares	591,620
Subsequent Events 30 | $ / shares	$ 0.009329
Subsequent Events 31 | shares	769,230
Subsequent Events 32 | $ / shares	$ 0.0126
Subsequent Events 35 | shares	500,000
Subsequent Events 36 | $ / shares	$ 0.00975
Subsequent Events 37 | shares	776,000
Subsequent Events 38 | $ / shares	$ 0.0075
Subsequent Events 39 | shares	775,000
Subsequent Events 40 | $ / shares	$ 0.00975
Subsequent Events 41 | shares	669,222
Subsequent Events 42 | $ / shares	$ 0.0075
Subsequent Events 43 | shares	750,312
Subsequent Events 44 | $ / shares	$ 0.009329
Subsequent Events 45 | shares	575,327
Subsequent Events 46 | $ / shares	$ 0.010985
Subsequent Events 47 | shares	790,000
Subsequent Events 48 | $ / shares	$ 0.007500
Subsequent Events 49 | shares	803,725
Subsequent Events 50 | $ / shares	$ 0.0075
Subsequent Events 51 | shares	846,153
Subsequent Events 52 | $ / shares	$ 0.00975
Subsequent Events 53 | shares	1,128,205
Subsequent Events 54 | $ / shares	$ 0.00975
Subsequent Events 55 | shares	819,493
Subsequent Events 56 | $ / shares	$ 0.010595
Subsequent Events 57 | shares	850,000
Subsequent Events 58 | $ / shares	$ 0.00975
Subsequent Events 59 | shares	1,041,960
Subsequent Events 60 | $ / shares	$ 0.0075
Subsequent Events 61 | shares	750,312
Subsequent Events 62 | $ / shares	$ 0.009329
Subsequent Events 63 | shares	750,000
Subsequent Events 64 | $ / shares	$ 0.0075
Subsequent Events 65 | shares	469,119
Subsequent Events 66 | $ / shares	$ 0.010595
Subsequent Events 67 | shares	1,048,416
Subsequent Events 68 | $ / shares	$ 0.007500
Subsequent Events 69 | shares	1,140,474
Subsequent Events 70 | $ / shares	$ 0.0075
Subsequent Events 71 | shares	1,100,000
Subsequent Events 72 | $ / shares	$ 0.00975
Subsequent Events 73 | shares	256,410
Subsequent Events 74 | $ / shares	$ 0.00975
Subsequent Events 75 | shares	923,077
Subsequent Events 76 | $ / shares	$ 0.0065
Subsequent Events 77 | shares	1,600,000
Subsequent Events 78 | $ / shares	$ 0.00715
Subsequent Events 79 | shares	1,500,000
Subsequent Events 80 | $ / shares	$ 0.0065
Subsequent Events 81 | shares	1,007,941
Subsequent Events 82 | $ / shares	$ 0.0065
Subsequent Events 83 | shares	769,231
Subsequent Events 84 | $ / shares	$ 0.0065
Subsequent Events 85 | shares	1,214,575
Subsequent Events 86 | $ / shares	$ 0.0076
Subsequent Events 87 | shares	1,529,480
Subsequent Events 88 | $ / shares	$ 0.007500
Subsequent Events 89 | shares	1,700,000
Subsequent Events 90 | $ / shares	$ 0.00494
Subsequent Events 91 | shares	1,700,000
Subsequent Events 92 | $ / shares	$ 0.00494
Subsequent Events 93 | shares	1,514,380
Subsequent Events 94 | $ / shares	$ 0.002
Subsequent Events 95 | shares	1,586,538
Subsequent Events 96 | $ / shares	$ 0.0026
Subsequent Events 97 | shares	1,000,000
Subsequent Events 98 | $ / shares	$ 0.002
Subsequent Events 99 | shares	2,302,321
Subsequent Events 100 | $ / shares	$ 0.00145
Subsequent Events 101 | shares	2,000,000
Subsequent Events 102 | $ / shares	$ 0.002
Subsequent Events 103 | shares	2,000,000
Subsequent Events 104 | $ / shares	$ 0.002
Subsequent Events 105 | shares	2,500,000
Subsequent Events 106 | $ / shares	$ 0.001625
Subsequent Events 107 | shares	5,500,000
Subsequent Events 108 | $ / shares	$ 0.00115
Subsequent Events 109 | shares	3,500,000
Subsequent Events 110 | $ / shares	$ 0.00125
Subsequent Events 122 | shares	6,100,000
Subsequent Events 123 | $ / shares	$ 0.00075
Subsequent Events 124 | $	$ 4,575
Subsequent Events 111 | shares	3,200,000
Subsequent Events 112 | $ / shares	$ 0.000750
Subsequent Events 113 | shares	3,100,000
Subsequent Events 114 | $ / shares	$ 0.000975
Subsequent Events 115 | shares	6,600,000
Subsequent Events 116 | $ / shares	$ 0.00075
Subsequent Events 117 | shares	6,000,000
Subsequent Events 118 | $ / shares	$ 0.00075
Subsequent Events 119 | shares	3,500,000
Subsequent Events 120 | $ / shares	$ 0.00975
Subsequent Events 121 | shares	2,500,000
Subsequent Events 122 | $ / shares	$ 0.001625
Subsequent Events 123 | shares	4,000,000
Subsequent Events 124 | $ / shares	$ 0.000845
Subsequent Events 125 | shares	9,717,385
Subsequent Events 126 | $ / shares	$ 0.00055
Subsequent Events 127 | shares	7,900,000
Subsequent Events 128 | $ / shares	$ 0.0065

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	$ 913,120
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	319,592
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	(699,718)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	(244,901)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	576,533
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	201,787
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	(399,010)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	(139,654)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	7,468
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	2,614
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	398,393
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13	139,438
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14	(398,393)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15	(139,438)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16	0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17	$ 0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1		35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2		$ 3,253,568
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3		1,138,749
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4		(118,990)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5		(41,647)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6		(103,048)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7		(36,067)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8		(1,483,168)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9		(519,109)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10		(1,333,192)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11		(466,617)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12		(624,429)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13		(218,550)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14		1,083,198
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15		379,119
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16		673,938
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17		235,878
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18		(673,938)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19		(235,878)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 20		0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 21		$ 0

Schedule of Summary of Converti

Schedule of Summary of Convertible Promissory Note (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 1	$ 67,913
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 2	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 3	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 4	(33,680)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 5	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 6	34,233
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 7	29,394
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 8	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 9	5,681
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 10	(29,938)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 11	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 12	5,137
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 13	540,498
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 14	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 15	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 16	(52,872)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 17	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 18	487,626
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 19	37,242
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 20	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 21	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 22	(5,200)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 23	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 24	32,042
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 25	75,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 26	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 27	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 28	(26,475)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 29	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 30	48,525
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 31	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 32	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 33	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 34	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 35	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 36	29,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 37	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 38	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 39	(3,000)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 40	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 41	26,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 42	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 43	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 44	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 45	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 46	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 47	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 48	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 49	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 50	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 51	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 52	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 53	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 54	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 55	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 56	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 57	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 58	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 59	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 60	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 61	12,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 62	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 63	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 64	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 65	12,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 66	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 67	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 68	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 69	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 70	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 71	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 72	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 73	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 74	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 75	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 76	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 77	18,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 78	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 79	17,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 80	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 81	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 82	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 83	17,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 84	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 85	24,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 86	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 87	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 88	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 89	24,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 90	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 91	5,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 92	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 93	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 94	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 95	5,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 96	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 97	13,200
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 98	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 99	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 100	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 101	13,200
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 102	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 103	12,100
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 104	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 105	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 106	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 107	12,100
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 108	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 109	40,700
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 110	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 111	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 112	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 113	40,700
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 114	879,047
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 115	253,750
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 116	5,681
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 117	(151,165)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 118	987,313
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 119	(345,053)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 120	(176,047)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 121	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 122	811,265
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 123	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 124	811,265
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 125	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 126	$ 0

Schedule of Valuation Assumptio

Schedule of Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016
August 3, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 2	269.35%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, August 3, 2015 3	0.17%
September 9, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 2	275.84%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 9, 2015 3	0.39%
September 30, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 2	375.79%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, September 30, 2015 3	0.33%
November 6, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 2	383.46%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, November 6, 2015 3	0.47%
December 1, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 2	392.28%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 2015 3	0.51%
December 1, 2015 Embedded Derivatives (2) [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 2	392.28%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 1, 20152 3	0.51%
December 3, 2015 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 2	394.55%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, December 3, 2015 3	0.57%
January 27, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 2	383.68%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate $24,750 3	0.47%
January 27, 2016 Embedded Derivatives (2) [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 2	383.68%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, January 27, 2016, Aggregate Of $5,500 3	0.47%
March 1, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 1, 2016 3	0.68%
March 24, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 24, 2016 3	0.64%
March 28, 2016 Embedded Derivatives [Member]
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 1	0.00%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 2	371.21%
Convertible Promissory Notes Schedule Of Valuation Assumptions, Embedded Derivatives, March 28, 2016 3	0.65%

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	$ 0
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	$ 0
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	346.6
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	453.3
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	258.89
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	0.39%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	0.66
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	0.11%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9	0.64

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value of Convertible Promissory Notes (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 1	$ 3,066,171
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 2	1,227,384
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 3	(3,174,990)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 4	527,883
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 5	1,646,448
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 6	836,980
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 7	(302,262)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 8	(829,133)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 9	1,352,033
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 10	$ 829,133

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 1	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 2	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 3	248
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 4	272.2
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 5	288.96
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 6	0.87
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 7	1.21
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 8	1.01
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 9	1.63

Schedule of Stockholders' Equ43

Schedule of Stockholders' Equity Warrants Activity (Details)	9 Months Ended
	Mar. 31, 2016USD ($)yr
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 1	$ 15,204
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 2	242.57
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 3 | yr	2.62
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 4	$ 19,104
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 5	236.92
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 6 | yr	4.46
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 7	$ (5,927)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 8	257.08
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 9	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 10	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 11	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 12	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 13	$ (1,289)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 14	240
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 15	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 16	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 17	100.98
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 18 | yr	3.79
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 19	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 20	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 21	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 22	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 23	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 24	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 25	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 26	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 27	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 28	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 29	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 30	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 31	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 32	100.99
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 33 | yr	3.04

Schedule of Changes in Fair V44

Schedule of Changes in Fair Value of Financial Liabilities (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 1	$ 5,416,000
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 2	791,407
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 3	(2,730,022)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 4	(3,334,009)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 5	143,376
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 6	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 7	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 8	252,160
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 9	395,536
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 10	$ 252,160

Schedule of Discontinued Operat

Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 1	$ 0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 2	54,476
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 3	(78,860)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 4	(363,442)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 5	(78,860)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 6	$ (305,966)

Schedule of Discontinued Oper46

Schedule of Discontinued Operations, Consolidated Balance Sheets (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 1	$ 5,731
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 2	46,731
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 3	653
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 4	28,160
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 5	683
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 6	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 7	16,284
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 8	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 9	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 10	(60,178)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 11	23,351
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 12	14,713
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 13	6,439
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 14	$ 6,696

Schedule of Effect on Condensed

Schedule of Effect on Condensed Consolidated Balance Sheet (Details)	9 Months Ended
	Mar. 31, 2016USD ($)shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 1	$ 64,099
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 2	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 3	64,098
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 4	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 6	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 7	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 9	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 10	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 12	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 13	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 14	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 15	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 16	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 17	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 18	115,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 19	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 20	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 21	115,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 22	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 24	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 25	3,134
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 26	140,241
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 27	143,375
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 28	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 29	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 30	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 31	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 32	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 33	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 34	300,887
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 35	233,107
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 36	533,994
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 37	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 39	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 40	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 41	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 42	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 43	551,701
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 44	2,019,796
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 45	2,571,497
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 46	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 47	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 48	$ 0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 49 | shares	7,574,353
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 50	$ 7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 51	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 52	7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 53	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 54	4,217,489
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 55	47,383,232
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 56	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 57	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 58	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 59	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 60	(6,237,285)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 61	(49,504,349)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 62	(123,230)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 63	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 64	(2,143,027)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 65	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 66	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 67	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 68	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 69	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 70	(2,456,477)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 71	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 72	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 73	$ 115,020

Schedule of Effect on Condens48

Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 1	$ 57,476
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 2	(57,476)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 3	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 4	31,212
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 6	31,212
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 7	1,308,405
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 8	(363,441)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 9	944,964
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 10	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 12	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 13	1,964,046
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 14	(363,441)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 15	1,600,605
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 16	(1,906,570)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 17	(305,965)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 18	(1,600,605)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 19	(2,818,008)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 20	1,484,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 21	(1,333,192)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 22	80,524
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 24	80,524
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 25	3,638,090
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 26	(1,763,485)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 27	1,874,605
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 28	(962,309)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 29	170,902
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 30	(791,407)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 31	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 32	(1,483,168)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 33	(1,483,168)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 34	(324)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 35	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 36	(324)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 37	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 38	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 39	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 40	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 41	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 43	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 44	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 45	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 46	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 47	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 48	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 49	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 50	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 51	(3,559,534)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 52	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 53	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 54	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 55	(1,818,674)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 56	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 57	$ (3,409,611)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 58	0.04
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 59	(15.24)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 60	(15.28)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 61	$ 44,636,800
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 62	(44,413,616)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 63	223,184
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 64	(1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 65	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 66	(3,559,534)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 67	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 68	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 69	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 70	(1,990,428)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 71	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 72	(3,581,365)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 73	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 74	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 75	(149,923)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 76	(1,840,505)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 77	(1,590,937)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 78	$ (3,431,442)

Schedule of Effect on Condens49

Schedule of Effect on Condensed Consolidated Statements of Cash Flows (Details)	9 Months Ended
	Mar. 31, 2016USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 1	$ (1,968,597)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 2	(1,284,971)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 3	(3,253,568)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 4	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 5	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 6	(305,966)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 7	324
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 9	324
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 10	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 12	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 13	5,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 14	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 15	5,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 16	2,611,775
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 17	(1,484,818)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 18	1,126,957
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 19	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 20	1,483,168
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 21	1,483,168
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 22	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 24	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 25	103,048
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 26	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 27	103,048
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 28	(3,638,090)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 29	1,763,485
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 30	(1,874,605)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 31	962,309
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 32	(170,902)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 33	791,407
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 34	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 35	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 36	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 37	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 39	624,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 40	(7,412)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 41	7,412
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 43	19,074
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 44	(2,464)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 45	16,610
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 46	103,185
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 47	2
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 48	103,187
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 49	52,968
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 50	(5,790)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 51	47,178
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 52	(887,997)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 53	(843)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 54	(898,840)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 55	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 56	(8,212)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 57	(8,212)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 58	(897,997)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 59	(9,055)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 60	(907,052)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 61	(45,332)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 62	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 63	(45,332)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 64	954,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 65	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 66	954,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 67	908,668
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 68	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 69	908,668
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 70	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 71	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 72	(21,831)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 73	(11,160)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 74	(9,055)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 75	(20,215)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 76	69,732
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 77	(12,100)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 78	57,632
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 79	58,572
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 80	(21,155)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 81	37,417
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 82	2,205
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 83	(2,205)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 84	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 85	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 86	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 87	2,536,097
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 88	(1,036,895)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 89	1,499,202
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 90	518,808
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 91	(518,808)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 92	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 93	779,600
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 94	1,663,170
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 95	2,442,770
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 96	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 97	2,312,157
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 98	2,312,157
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 99	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 100	901,327
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 101	901,327
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 102	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 103	2,018,791
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 104	$ 2,018,791

Schedule of Effect on Condens50

Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit (Details)	9 Months Ended
	Mar. 31, 2016USD ($)shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 1	$ 38,573,856
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 2	538,043
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 3	39,111,899
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 4	3,636,984
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 5	(1,457,586)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 6	2,179,398
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 7	767,879
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 8	1,962,041
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 9	2,729,920
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 10	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 11	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 12	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 13	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 14	4,217,488
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 15	47,383,231
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 16	(40,821,871)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 17	(6,166,108)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 18	(46,987,979)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 19	(2,445,193)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 20	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 21	(2,516,369)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 22	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 23	(6,237,283)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 24	(49,504,347)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 25	(2,355,136)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 26	$ (5,628,065)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 27 | shares	(7,983,201)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 28	$ 118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 29	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 30	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 31	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 32	767,981
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 33	1,962,039
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 34	2,730,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 35	3,644,405
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 36	(1,457,585)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 37	2,186,820
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 39	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 40	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 41	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 43	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 44	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 45	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 46	(2,657,243)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 47	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 48	(2,728,419)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 49	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 50	(2,019,797)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 51	$ (2,456,477)